Health TrialsbyHealthPanel

The Heart Hive - Cardiomyopathy Study

ConditionsCardiomyopathiesMyocarditis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorImperial College London

About this trial

This is an online registry and database of patients with cardiomyopathy and myocarditis, coupled with an observational study of cardiomyopathies.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult (age 18 and over),

Males and Females,

Capacity to provide informed consent,

Patients with a confirmed diagnosis of cardiomyopathy or myocarditis,

Disqualifiers

Patients who lack capacity to consent for themselves,

Vulnerable groups (e.g. those under 18, prisoners, those in a dependent relationship, the mentally ill).

who have been informed by their treating physician that their cardiomyopathy is secondary to their coronary artery disease, or

who have undergone previous percutaneous coronary intervention or coronary bypass surgery

Trial population

Eligible adult patients with cardiomyopathy in The Heart Hive registry

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Research genetic analysis

    Genetic

    Genetic analysis of DNA extracted from saliva. Participants can opt in to receive individual results of research genetic analysis for a predefined panel of clinically actionable cardiomyopathy genes.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Number of participants with cardiovascular cause of death

Cardiovascular death

Time frame
90 years
2

Number of participants with arrhythmic events

(ventricular fibrillation, unstable sustained ventricular tachycardia, appropriate implantable cardioverter-defibrillator delivered shock, and aborted sudden cardiac death

Time frame
90 years
3

Number of participants with major heart failure events

heart transplantation, left ventricular assist device implantation, unplanned heart failure, hospitalisation

Time frame
90 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Imperial College London

Lead sponsor

Source ClinicalTrials.gov
Apply now